Skip to main content
. 2022 Mar 15;6(6):1742–1753. doi: 10.1182/bloodadvances.2021004821

Figure 2.

Figure 2.

Duration of response. Duration of CHR of patients who achieved CHR in the study, from diagnosis to death or loss of CHR (A); duration of CCyR of patients who achieved CCyR in the study, from diagnosis to death or loss of CCyR (B); and duration of CMR of the patients who achieved CMR in the study, from diagnosis to death or loss of CMR (C).